Skip to main content
Log in

Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective.

The aim of this study was to investigate whether serial serum neuron-specific enolase (NSE) can be used to predict neurological prognosis in patients remaining comatose after cardiopulmonary resuscitation (CPR).

Design.

Observational cohort study. Clinicians were blinded to NSE results.

Setting.

Eighteen-bed general ICU.

Patients.

Comatose patients admitted to the ICU after CPR.

Interventions.

Serum NSE was measured at admission and daily for 5 days.

Measurements and results.

Patients received full intensive treatment until recovery or until absence of cortical response to somatosensory evoked potentials more than 48 h after CPR proved irreversible coma. Of the 110 patients included (mean GCS at ICU admission 3, range 3––9), 34 regained consciousness, five of whom died in hospital. Seventy-six patients did not regain consciousness, 72 of whom died in hospital. Serum NSE at 24 h and at 48 h after CPR was significantly higher in patients who did not regain consciousness than in patients who regained consciousness (at 24 h: median NSE 29.9 µg/l, range 1.8–250 vs 9.9 µg/l, range 4.5–21.5, P <0.001; at 48 h: median 37.8 µg/l, range 4.4–411 vs 9.5 µg/l, range 6.2–22.4, P = 0.001). No patient with a serum NSE level >25.0 µg/l at any time regained consciousness. Addition of NSE to GCS and somatosensory evoked potentials increased predictability of poor neurological outcome from 64% to 76%.

Conclusions.

High serum NSE levels in comatose patients at 24 h and 48 h after CPR predict a poor neurological outcome. Addition of NSE to GCS and somatosensory evoked potentials increases predictability of neurological outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Zandbergen EG, de Haan RJ, Stoutenbeek CP, Koelman JH, Hijdra A (1998) Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet 352:1808–1812

    CAS  PubMed  Google Scholar 

  2. van de Wetering J, van der Hoeven JG, van Dijk JG, Meinders AE (1997) When to stop treatment in comatose patients after successful cardiopulmonary resuscitation? A practical approach. Neth J Med 51:91–95

    Article  PubMed  Google Scholar 

  3. Gendo A, Kramer L, Hafner M, Funk GC, Zauner C, Sterz F, Holzer M, Bauer E, Madl C (2001) Time-dependency of sensory evoked potentials in comatose cardiac arrest survivors. Intensive Care Med 27:1305–1311

    Article  CAS  PubMed  Google Scholar 

  4. Nakabayashi M, Kurokawa A, Yamamoto Y (2001) Immediate prediction of recovery of consciousness after cardiac arrest. Intensive Care Med 27:1210–1214

    Article  CAS  PubMed  Google Scholar 

  5. Schaarschmidt H, Prange HW, Reiber H (1994) Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 25:558–565

    CAS  PubMed  Google Scholar 

  6. Zandbergen EG, de Haan RJ, Hijdra A (2001) Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med 27:1661–1667

    Article  CAS  PubMed  Google Scholar 

  7. Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M (1991) Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol 14:237–245

    CAS  PubMed  Google Scholar 

  8. Fogel W, Krieger D, Veith M, Adams HP, Hund E, Storch-Hagenlocher B, Buggle F, Mathias D, Hacke W (1997) Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 25:1133–1138

    Google Scholar 

  9. Stelzl T, von Bose MJ, Hogl B, Fuchs HH, Flugel KA (1995) A comparison of the prognostic value of neuron-specific enolase serum levels and somatosensory evoked potentials in 13 reanimated patients. Eur J Emerg Med 2:24–27

    CAS  PubMed  Google Scholar 

  10. Martens P, Raabe A, Johnsson P (1998) Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 29:2363–2366

    CAS  PubMed  Google Scholar 

  11. Martens P (1996) Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors. Acad Emerg Med 3:126–131

    CAS  PubMed  Google Scholar 

  12. Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner AN (1999) Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30:1598–1603

    CAS  PubMed  Google Scholar 

  13. Karkela J, Bock E, Kaukinen S (1993) CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE), and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci 116:100–109

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iwan A. Meynaar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meynaar, I.A., Straaten, H.M.Ov., van der Wetering, J. et al. Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med 29, 189–195 (2003). https://doi.org/10.1007/s00134-002-1573-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-002-1573-2

Keywords.

Navigation